# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Baird analyst Eric Coldwell maintains Owens & Minor (NYSE:OMI) with a Neutral and lowers the price target from $28 to $24.
Owens & Minor impresses with Q1 results: adjusted EPS of $0.19, and sales of $2.61B (up 4% Y/Y). Patient Direct revenue rea...